Shankar Balasubramanian

Co-Founder at Cambridge Epigenetix Ltd.

Shankar Balasubramanian

Shankar Balasubramanian

Co-Founder at Cambridge Epigenetix Ltd.

Biography

Founder of Solexa, Inc. and Cambridge Epigenetix Ltd., Shankar Balasubramanian is on the board of Cambridge Epigenetix Ltd. and Professor at the University of Cambridge.

Overview

Career Highlights

Cambridge Epigenetix Ltd.
Solexa, Inc.

RelSci Relationships

470

Number of Boards

1

Relationships

View Relationship Details

RelSci Relationships are individuals Shankar Balasubramanian likely has professional access to. A relationship does not necessarily indicate a personal connection.

Bobby Satyadev Yerramilli-Rao

Co-Founder at Cambridge Epigenetix Ltd.

Relationship likelihood: Strong

Martin Murphy

Chief Executive Officer at Syncona Ltd.

Relationship likelihood: Strong

Timothy J. Rink

Advisor at Avelas Biosciences, Inc.

Relationship likelihood: Strong

Thomas William Hulme

General Partner at GV Management Co. LLC

Relationship likelihood: Strong

Jason Mellad

Chief Executive Officer at Start Codon

Relationship likelihood: Strong

Roelof F. Botha

Partner at Sequoia Capital

Relationship likelihood: Strong

Somasundaram Subramaniam

Co-Founder & Managing Partner at New Science Ventures LLC

Relationship likelihood: Strong

Suman Shirodkar

Chief Executive Officer at Cambridge Epigenetix Ltd.

Relationship likelihood: Strong

Alice Newcombe-Ellis

Founder & Managing Partner at Ahren Innovation Capital LLP

Relationship likelihood: Strong

Gail Marcus

Assistant Professor at Hofstra University

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

ENP Newswire

August 24, 2020

-University of Cambridge - The chemist who fuses fashion with science

Targeted News Service

August 4, 2020

University of Cambridge: Four-Stranded DNA Structures Found to Play Role in Breast Cancer

Business Wire

January 8, 2019

Cambridge Epigenetix announces programme for routine screening and detection of colorectal cancer and other common tumours

ENP Newswire

November 8, 2017

-University of Nottingham - Nottingham celebrates 70th anniversary of the discovery of hydrogen bonds in DNA

Time Magazine

October 12, 2017

Nobel Laureate: The Future of DNA Sequencing Will Be in the Palm of Your Hand

Paths to Shankar Balasubramanian

Potential Connections via
Relationship Science

You

Shankar Balasubramanian

Co-Founder at Cambridge Epigenetix Ltd.

Career History

Co-Founder

2012 - Current

Cambridge Epigenetix Ltd.

Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom.

Professor

Current

University of Cambridge

The University of Cambridge (informally known as Cambridge University or Cambridge) is a public research university located in Cambridge, United Kingdom. It is the second-oldest university in the English-speaking world (after the University of Oxford), and the seventh-oldest in the world.

Founder

Prior

Solexa, Inc.

Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA.

Investments

Details Hidden

Cambridge Epigenetix Ltd.

Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom.

Other Affiliations

Shankar Balasubramanian is affiliated with Cambridge Epigenetix Ltd., University of Cambridge, Solexa, Inc.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Shankar Balasubramanian. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Shankar Balasubramanian's profile does not indicate a business or promotional relationship of any kind between RelSci and Shankar Balasubramanian.